Flurizan Shows
Benefits for Treating Alzheimer's Disease - Slows Onset of Confusion
Depression and Aggression Over 24 Month Period
July 19th 2006
|
 |
|
Flurizan Benefits |
|
Researchers have demonstrated Flurizan can help patients with
Alzheimer’s disease. Flurizan, made by Myriad Genetics, when given in
the larger doses (800 milligram twice a day) can slow the cognitive
decline caused by Alzheimer ’s disease.
In this study, the groups taking the higher doses demonstrated a
substantial benefit over other dose groups in the study and that this
benefit continued over 24 months. The testing included memory loss,
cognition and global function.
This is considered a small mid-state trial, but the results are
promising. Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals,
Inc. said "The 24 month data completes the Phase 2 follow-on trial with
mounting evidence of efficacy against mild Alzheimer's disease that
consistently increased over the course of the study. The results are
consistent with a mode of action for Flurizan that is modifying the
course of the underlying disease process."
|